Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.
Northern Oil & Gas, Inc. engages in the acquisition, exploration, development, and production of crude oil and natural gas properties. It focuses on the Bakken and Three Forks formation within the Williston Basin in North Dakota and Montana. The company was founded by Michael Lewis Reger in 2006 and is headquartered in Minnetonka, MN.
UTStarcom Holdings Corp. is a telecom infrastructure company, which develops technology for cloud-based services, mobile, streaming, and other applications. It operates through the following segments: Equipment, and Services. The Equipment segment focuses on equipment sales including network infrastructure and application products, which include broadband products, wireless infrastructure technologies. The Services segment provides services and support for equipment products and also the new operational support segment. The company was founded in 1991 and is headquartered in Hangzhou, China.
DSS, Inc. engages in the development and distribution of paper products designed to protect valuable information from unauthorized scanning, copying, and digital imaging. It operates through the following segments: Product Packaging, Commercial Lending, Biotechnology, Direct Marketing, and Securities and Investment Management. The Product Packaging segment operates in the paper board folding carton, smart packaging, and document security printing markets. The Commercial Lending segment provides commercial loans and on acquiring equity positions in undervalued commercial bank(s), bank holding companies and non-banking licensed financial companies operating in the United States, Southeast Asia, Taiwan, Japan, and South Korea. The Biotechnology segment invests in or acquires companies in the bio-health and bio-medical fields, including businesses focused on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases. The Direct Marketing segment provides services to assist companies in the emerging growth big business model of peer-to-peer decentralized sharing marketplaces. The Securities and Investment Management segment develops and acquires assets and investments in the securities trading and funds management arena and to pursue, among other product and service lines, real estate investment funds, broker dealers and mutual funds management. The company was founded in May 1984 and is headquartered in West Henrietta, NY.
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.